학술논문
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme
Document Type
Article
Author
Source
In: United European Gastroenterology Journal . (United European Gastroenterology Journal, April 2022, 10(3):330-343)
Subject
Language
English
ISSN
20506414
20506406
20506406